Andres Alberto Mercado Pompa: External Validation of Prognostic Risk Scores in Cerebral Venous Thrombosis
Andres Alberto Mercado Pompa, Concussion Management at Liga Bancomer MX, shared a post on LinkedIn about a recent article he and his colloagues co-authored, published in Clinical Neurology and Neurosurgery, adding:
“Happy to share the results of an exciting international collaboration:
‘Performance of Prognostic Risk Scores in Cerebral Venous Thrombosis: External Validation in the CLOT-VENUS Registry.’
In the CLOT-VENUS Registry, we externally evaluated the performance of three prognostic models for cerebral venous thrombosis:
ISCVT-RS, CVT-GS, and IN-REvASC, examining their discrimination, calibration, and accuracy.
We found moderate discriminatory performance across the evaluated prognostic scores, without significant differences between models, highlighting both their potential utility and the need for further refinement of prognostic tools in CVT.
I am especially grateful to Dr. Antonio Arauz, Dr. Santiago Ortega, and his team at the University of Iowa for the opportunity to collaborate on this project, as well as to all the investigators who contributed to the study.
Free access until November 1, 2026.”
Title: Performance of Prognostic Risk Scores in Cerebral Venous Thrombosis: External Validation in the CLOT-VENUS Registry
Authors: Nashwa Abdelhakim, Milagros Galecio-Castillo, Leonardo Cruz-Criollo, Anderson Brito, Aaron Rodriguez-Calienes, Eric Kontowicz, Amir Shaban, Vanessa Cano Nigenda, Andres Alberto Mercado Pompa, Adrian Pereda-Castillo, Hector Valdez Ruvalcaba, Brian J. Smith, Miguel A. Barboza, Antonio Arauz, Santiago Ortega-Gutierrez
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 30, 2026, 17:43Santagata Davide: Can Targeting Inflammation Help Prevent Thrombosis?
-
Oct 30, 2026, 17:38Patrick Ellsworth: Supporting Patients and Families Through Bleeding Disorders Awareness and Community Initiatives
-
Oct 30, 2026, 17:33Ed Shovelin: Comparative Hemostatic Performance of CRP-A and Equine Fibrillar Collagen
-
Oct 30, 2026, 16:52Tosin Ola: A New Era in Sickle Cell Disease Treatment and the Question of Access
-
Oct 30, 2026, 16:48Cedric Hermans: The Next Generation of FVIIIa-Mimetic Antibodies in Haemophilia A
-
Oct 30, 2026, 16:44Shehab Mohamed: Recognizing Isolated Thrombocytopenia as a Presentation of MDS
-
Oct 30, 2026, 16:40Amrita Sarkar: Advancing the Diagnosis of Anti-PF4 Syndromes
-
Oct 30, 2026, 16:35James Garrard: Driving Innovation in Stroke Care Through Global Collaboration
-
Oct 30, 2026, 16:19Cesar de Almeida Neto: Hemo 2026 Roundtable Focuses on the Challenges of Patient Blood Management